We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




New Tumor Defense System Discovered

By Biotechdaily staff writers
Posted on 23 Aug 2005
Scientists have found that tumors discharge fatty acids that interfere with the cells that are trying to destroy them. More...
As a result, new strategies that decrease the amount of fatty acids around the tumors may provide new approaches to anticancer treatment.

Several types of anticancer therapy are based on immunotherapeutic anti-cancer strategies, therapies that boost the body's immune system, such as cytotoxic T lymphocytes, to help destroy tumors. However, immunotherapeutic techniques are frequently not effective at removing established tumors for a variety of reasons including a loss of the ability of the cytotoxic T lymphocytes to recognize the tumor and a physical barrier separating the tumor and the lymphocytes.

Now, researchers from the Torrey Pines Institute for Molecular Studies (San Diego, CA, USA) have added another reason to this inventory. They found that tumors secrete fatty acids which suppress the cytotoxic T lymphocytes' ability to destroy tumor cells. Their findings were published in the September 2005 issue of the Journal of Lipid Research.

"We found two things,” explained Dr. Alan M. Kleinfeld. "First, the most common type of free fatty acids, which at normal levels are essential for life, at high levels prevents the cytotoxic T lymphocytes from destroying tumor cells. The second thing is that human breast cancer cells, but not normal tissue from the same breast, produce very large amounts of the type of free fatty acids that block the cytotoxic T lymphocytes. Thus, the cancer may have a way of defending itself against attack by the immune system, thereby reducing the potential efficacy of novel anti-cancer therapies that rely on a functioning immune system.”

The free fatty acids work against cytotoxic T lymphocytes by inhibiting a number of the lymphocytes' signaling processes. For example, they keep specific proteins from being phosphorylated and they also prevent an increase in intracellular calcium that is vital for the cytotoxic T lymphocytes to destroy the tumor cells. Dr. Kleinfeld believes that these signaling mechanisms are being blocked at the cells' membranes.

These findings raise the possibilities of new therapeutic targets for cancer, such as those that may move free fatty acids out of the tumor. Furthermore, free fatty acid levels in the blood could be utilized to help evaluate the aggressive potential of a tumor.






Related Links:
Torrey Pines Institute for Molecular Studies

Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Melanoma Panel
UltraSEEK Melanoma Panel
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.